HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Core Assets of Southward Funds

1,116.171

-21.951-1.93%

Number of Gainers:18

Number of Losers:46

Number of Flat:3

PE:- -

High:1,141.060

Open:1,137.460

Low:1,102.736

Close:1,138.122

Loading ...

Budweiser Brewing Co APAC - FY Normalized Profit Attributable $778 Mln

THOMSON REUTERS

Budweiser Brewing Co APAC - Recommends Final Dividend of 5.66 USD Cents per Share

THOMSON REUTERS

BRIEF-China Literature Sees IFRS Net Loss Of RMB150 Mln To RMB250 Mln For Year

China Literature Sees Ifrs Net Loss of RMB150 Mln to RMB250 Mln for Year

THOMSON REUTERS

China Literature - Expected Result Due to Non-Cash Impairment of Goodwill

THOMSON REUTERS

Amer Sports CFO Says Company Is "Well Equipped to Weather a Variety of Tariff Scenarios"

THOMSON REUTERS

Amer Sports CFO, on Tariffs, Says Sourcing to U.S. From China, Vietnam, Canada, and Mexico Together Accounted for 20% of Sourcing

THOMSON REUTERS

Hansoh Pharmaceutical Group's Anti-Hives Capsule Obtains Chinese Regulator's Approval for Clinical Trials

MT Newswires Live

Chinese Regulator Designates Hansoh Pharmaceutical Group's Injection as Breakthrough-Therapy Drug for Bone Cancer

MT Newswires Live

BRIEF-Hansoh Pharmaceutical Says NMPA Granted Approval For HS-20093

BUZZ-Amer Sports down after annual forecasts largely miss expectations

BRIEF-Hansoh Pharmaceutical Receives Clinical Trial Approval For Hs-10561 Capsules Issued By NMPA

Hansoh Pharmaceutical - Nmpa Granted Breakthrough-Therapy-Designated Drug for B7-H3-Targeted Antibody-Drug Conjugate Hs-20093

THOMSON REUTERS

Hansoh Pharmaceutical - Clinical Trial Approval for Hs-10561 Capsules Issued by Nmpa

THOMSON REUTERS

Renault Shares Slip 3.5% After Jefferies Cuts to 'Hold'

THOMSON REUTERS

China Conch Environment Unit Renews Cement Kiln Deal with CNBM

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1589/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1589"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1589\",,,,,undefined,":{"symbol":"BK1589","market":"HK","secType":"PLATE","nameCN":"Core Assets of Southward Funds","latestPrice":1116.1705,"timestamp":1741594026654,"preClose":1138.1217,"halted":0,"volume":2411726716,"delay":0,"changeRate":-0.019287,"change":-21.951172,"pbRate":2.29469,"amount":68313903112.6,"amplitude":0.033674,"prevYearClose":949.2231,"fiveDayClose":1059.923,"twentyDayClose":995.171,"turnoverRate":0.005359,"marketCap":15605995490304,"floatMarketCap":14586338806784,"peRate":22.961507},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1589\",,,,,undefined,":{"symbol":"BK1589","high":1141.0604,"amplitude":0.033674,"preClose":1138.1217,"low":1102.7356,"pbRate":"2.29469","latestPrice":1116.1705,"volume":2411726716,"delay":0,"open":1137.46,"prevYearClose":949.2231,"prevWeekClose":1138.122,"prevMonthClose":1057.801,"prevQuarterClose":949.223,"fiveDayClose":1059.923,"twentyDayClose":995.171,"sixtyDayClose":931.214,"secType":"PLATE","market":"HK","turnoverRate":0.005359,"peRate":22.961507,"marketCap":15605995490304,"floatMarketCap":14586338806784,"timestamp":1741594026654,"nameCN":"Core Assets of Southward Funds"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1589\",,,,undefined,":{"bkCode":"BK1589","up":18,"down":46,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1589\",pageSize:16,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514282970","title":"Budweiser Brewing Co APAC - FY Normalized Profit Attributable $778 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514282970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514282970?lang=en_us&edition=fundamental","pubTime":"2025-02-26 07:00","pubTimestamp":1740524451,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG11E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1589","LU0630378692.HKD","LU0543330483.HKD","LU0630378429.USD","SG9999000459.SGD","BK1510","LU0831093199.SGD","BK1180","LU0029875118.USD","LU0320764755.SGD","BK1578","LU0762541174.USD","LU0197773673.USD","LU0672654166.SGD","LU0762540952.USD","01876","LU0128522157.USD","LU0762542818.HKD","BK1604","LU0197773160.USD","SG9999001903.USD"],"gpt_icon":0},{"id":"2514028257","title":"Budweiser Brewing Co APAC - Recommends Final Dividend of 5.66 USD Cents per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2514028257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514028257?lang=en_us&edition=fundamental","pubTime":"2025-02-26 07:00","pubTimestamp":1740524451,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG11E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0762541174.USD","LU0128522157.USD","LU0543330483.HKD","LU0672654166.SGD","LU0630378692.HKD","BK1180","SG9999000459.SGD","BK1510","LU0762542818.HKD","LU0831093199.SGD","BK1578","LU0762540952.USD","01876","LU0029875118.USD","LU0197773673.USD","BK1604","BK1589","SG9999001903.USD","LU0320764755.SGD","LU0197773160.USD","LU0630378429.USD"],"gpt_icon":0},{"id":"2514652094","title":"BRIEF-China Literature Sees IFRS Net Loss Of RMB150 Mln To RMB250 Mln For Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2514652094","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514652094?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:48","pubTimestamp":1740491331,"startTime":"0","endTime":"0","summary":"BRIEF-China Literature Sees IFRS Net Loss Of RMB150 Mln To RMB250 Mln For YearFeb 25  - China Literature Ltd 0772.HK:SEES IFRS NET LOSS OF RMB150 MILLION TO RMB250 MILLION FOR 2024 FINANCIAL YEARSEES IMPAIRMENT OF GOODWILL OF RMB1,050 MILLION TO RMB1,150 MILLION. FOR YEAREXPECTED RESULT DUE TO NON-CASH IMPAIRMENT OF GOODWILLFurther company coverage: 0772.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG0D6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00772","BK1589","BK1516","BK1130"],"gpt_icon":0},{"id":"2514609498","title":"China Literature Sees  Ifrs Net Loss of RMB150 Mln to RMB250 Mln for Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2514609498","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514609498?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:47","pubTimestamp":1740491252,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG0D6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00772","BK1130","BK1589","BK1516"],"gpt_icon":0},{"id":"2514094956","title":"China Literature -  Expected Result Due to Non-Cash Impairment of Goodwill","url":"https://stock-news.laohu8.com/highlight/detail?id=2514094956","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514094956?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:47","pubTimestamp":1740491252,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG0D6:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1589","00772","BK1516","BK1130"],"gpt_icon":0},{"id":"2514091208","title":"Amer Sports CFO Says Company Is \"Well Equipped to Weather a Variety of Tariff Scenarios\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2514091208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514091208?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:39","pubTimestamp":1740490796,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL5N3PG19J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANPDY","IE00BQXX3C00.GBP","BK1500","LU0261947096.USD","02020","BK4202","LU0326950275.SGD","LU0594300179.USD","IE00B031HY20.USD","LU0594300419.USD","LU0605514214.HKD","LU1831875114.USD","LU0251144936.SGD","LU2039709279.SGD","LU0048597586.USD","IE0008369823.USD","LU1188198961.HKD","BK1521","LU0463099449.HKD","LU0320764599.SGD","BK1227","IE0008368742.USD","IE00BQXX3D17.EUR","LU0140636845.USD","IE00BQXX3F31.USD","AS","BK1502","IE00BGV7N243.SGD","BK1168","LU0708995583.HKD","LU0244354667.USD","IE00B031J352.USD","BK1512","IE0031814852.USD","LU2488822045.USD","LU0650527681.SGD","BK1589","82020","LU0052750758.USD"],"gpt_icon":0},{"id":"2514912770","title":"Amer Sports CFO, on Tariffs, Says Sourcing to U.S. From China, Vietnam, Canada, and Mexico Together Accounted for 20% of Sourcing","url":"https://stock-news.laohu8.com/highlight/detail?id=2514912770","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514912770?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:39","pubTimestamp":1740490795,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL5N3PG19J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0048597586.USD","IE0008368742.USD","IE00B031HY20.USD","ANPDY","IE0031814852.USD","LU0605514214.HKD","IE00BQXX3D17.EUR","LU2039709279.SGD","LU0261947096.USD","LU0650527681.SGD","LU0326950275.SGD","BK4202","IE00BGV7N243.SGD","LU0052750758.USD","IE00B031J352.USD","LU0463099449.HKD","LU1831875114.USD","LU1188198961.HKD","IE00BQXX3C00.GBP","82020","BK1227","BK1521","AS","LU0140636845.USD","LU0244354667.USD","BK1500","BK1502","02020","LU0320764599.SGD","BK1168","IE0008369823.USD","BK1512","IE00BQXX3F31.USD","LU0708995583.HKD","LU2488822045.USD","LU0594300419.USD","LU0251144936.SGD","LU0594300179.USD","BK1589"],"gpt_icon":0},{"id":"2514096805","title":"Hansoh Pharmaceutical Group's Anti-Hives Capsule Obtains Chinese Regulator's Approval for Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2514096805","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514096805?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:50","pubTimestamp":1740487802,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group's  HS-10561 capsules obtained China's National Medical Products Administration's approval for clinical trials to be tested for spontaneous hives, a Tuesday bourse filing said.The capsules, Category 1 small molecule Bruton's tyrosine kinase inhibitor  HS-10561, are jointly developed by the group and Guangzhou Lupeng Pharmaceutical.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","03692","BK1583","BK1589"],"gpt_icon":0},{"id":"2514950670","title":"Chinese Regulator Designates Hansoh Pharmaceutical Group's Injection as Breakthrough-Therapy Drug for Bone Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2514950670","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514950670?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:46","pubTimestamp":1740487571,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group's  HS-20093 for injection obtained China's National Medical Products Administration's  approval to be added as a breakthrough-therapy-designated drug for the treatment of patients with osteosarcoma, a type of bone cancer, a Tuesday bourse filing said.The Chinese regulator approved the drug for the treatment of patients who have progressed on at least two prior lines of therapy.HS-20093, also known as GSK5764227, is a B7-H3-targeted antibody-drug conjugate that is being developed in multiple clinical studies of small-cell lung cancer, head and neck cancers, and other solid tumors.The injection has also been granted breakthrough therapy designation by NMPA previously for lung cancer and from the US Food and Drug Administration for the treatment of relapsed or refractory extensive-stage small-cell lung cancer, ES-SCLC.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","03692","BK1583","BK1589"],"gpt_icon":0},{"id":"2514909332","title":"BRIEF-Hansoh Pharmaceutical Says NMPA Granted Approval For HS-20093","url":"https://stock-news.laohu8.com/highlight/detail?id=2514909332","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514909332?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:13","pubTimestamp":1740485624,"startTime":"0","endTime":"0","summary":"BRIEF-Hansoh Pharmaceutical Says NMPA Granted Approval For HS-20093Feb 25 (Reuters) - Hansoh Pharmaceutical 3692.HK:NMPA GRANTED BREAKTHROUGH-THERAPY-DESIGNATED DRUG FOR B7-H3-TARGETED ANTIBODY-DRUG CONJUGATE HS-20093Further company coverage: 3692.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG0C3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1191","BK1589","BK1583"],"gpt_icon":0},{"id":"2514441067","title":"BUZZ-Amer Sports down after annual forecasts largely miss expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2514441067","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514441067?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:29","pubTimestamp":1740482974,"startTime":"0","endTime":"0","summary":"BUZZ-Amer Sports down after annual forecasts largely miss expectations** Shares of Amer Sports AS.N fall ~3% to $27.60 premarket** Co forecasts annual revenue growth between 13% and 15%, the midpoint of which falls below analysts' expectations of a 14.9% growth - data compiled by LSEG** Says revenue forecast assumes drag from unfavorable currency exchange impact** Annual EPS expectations of between 64 cents and 69 cents also largely below estimate of 68 cents** Q4 revenue, which rose 23% to $1.64 billion, narrowly beat estimate of $1.60 billion, while adjusted EPS of 17 cents was in line with expectations** As of last close, AS has risen 120% since its February 2024 IPO  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3N3PG0ZA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0048597586.USD","IE0008368742.USD","IE00B031HY20.USD","ANPDY","IE0031814852.USD","LU0605514214.HKD","IE00BQXX3D17.EUR","LU2039709279.SGD","LU0261947096.USD","LU0650527681.SGD","LU0326950275.SGD","BK4202","IE00BGV7N243.SGD","LU0052750758.USD","IE00B031J352.USD","LU0463099449.HKD","LU1831875114.USD","LU1188198961.HKD","IE00BQXX3C00.GBP","82020","BK1227","BK1521","AS","LU0140636845.USD","LU0244354667.USD","BK1500","BK1502","02020","LU0320764599.SGD","BK1168","IE0008369823.USD","BK1512","IE00BQXX3F31.USD","LU0708995583.HKD","LU2488822045.USD","LU0594300419.USD","LU0251144936.SGD","LU0594300179.USD","BK1589"],"gpt_icon":0},{"id":"2514641210","title":"BRIEF-Hansoh Pharmaceutical Receives Clinical Trial Approval For Hs-10561 Capsules Issued By NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2514641210","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514641210?lang=en_us&edition=fundamental","pubTime":"2025-02-25 18:57","pubTimestamp":1740481033,"startTime":"0","endTime":"0","summary":"BRIEF-Hansoh Pharmaceutical Receives Clinical Trial Approval For Hs-10561 Capsules Issued By NMPAFeb 25 (Reuters) - Hansoh Pharmaceutical Group Company Ltd 3692.HK:CLINICAL TRIAL APPROVAL FOR HS-10561 CAPSULES ISSUED BY NMPAFurther company coverage: 3692.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG0JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1589","BK1583","BK1191"],"gpt_icon":0},{"id":"2514406416","title":"Hansoh Pharmaceutical - Nmpa Granted Breakthrough-Therapy-Designated Drug for B7-H3-Targeted Antibody-Drug Conjugate Hs-20093","url":"https://stock-news.laohu8.com/highlight/detail?id=2514406416","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514406416?lang=en_us&edition=fundamental","pubTime":"2025-02-25 18:55","pubTimestamp":1740480957,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG0C3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1589","BK1583","03692"],"gpt_icon":0},{"id":"2514646100","title":"Hansoh Pharmaceutical -  Clinical Trial Approval for Hs-10561 Capsules Issued by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2514646100","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514646100?lang=en_us&edition=fundamental","pubTime":"2025-02-25 18:49","pubTimestamp":1740480596,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG0JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03692","BK1191","BK1589","BK1583"],"gpt_icon":0},{"id":"2514051341","title":"Renault Shares Slip 3.5% After Jefferies Cuts to 'Hold'","url":"https://stock-news.laohu8.com/highlight/detail?id=2514051341","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514051341?lang=en_us&edition=fundamental","pubTime":"2025-02-25 16:01","pubTimestamp":1740470484,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PF252:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1119","00175","GELYY","IE00B0JY6N72.USD","IE00BZ08YS42.EUR","LU0293314216.USD","LU1224444064.USD","LU0315179316.USD","LU1282651121.HKD","EVS.SI","SG9999002828.SGD","IE00BZ08YT58.USD","BK1521","LU1282651048.USD","80175","IE00BZ08YR35.GBP","BK1589","BK1539"],"gpt_icon":0},{"id":"2514188056","title":"China Conch Environment Unit Renews Cement Kiln Deal with CNBM","url":"https://stock-news.laohu8.com/highlight/detail?id=2514188056","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514188056?lang=en_us&edition=fundamental","pubTime":"2025-02-25 15:39","pubTimestamp":1740469163,"startTime":"0","endTime":"0","summary":"China Conch Environment Protection Holdings  subsidiary Haizhong Environmental will continue to tap China National Building Material or CNBM  to supply it with cement kiln co-treatment services and related supporting services for another three years.The parties renewed their agreement following its expiry on Dec. 31, 2024, a Monday bourse filing said.The new term started on Jan. 1, 2025, and expires on Dec. 31, 2027.The annual caps for the fees to be incurred under the renewed agreement are 50 million yuan for 2025, 51 million yuan for 2026, and 53 million yuan for 2027.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1503","03323","BK1594","BK1563","00587","BK1135","BK1140","BK1589"],"gpt_icon":0}],"pageSize":16,"totalPage":12,"pageCount":11,"totalSize":190}]}}